Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)

China · Delayed Price · Currency is CNY

30.54

+0.72 (2.41%)

Jun 23, 2026, 3:00 PM CST

-16.92% (1Y)

Market Cap	3.79B -20.8%
Revenue (ttm)	407.16M -22.7%
Net Income	25.03M -84.0%
EPS	0.20 -84.0%
Shares Out	127.08M
PE Ratio	151.40
Forward PE	n/a
Dividend	0.80 (2.65%)
Ex-Dividend Date	n/a

Volume	656,254
Open	29.63
Previous Close	29.82
Day's Range	29.60 - 30.84
52-Week Range	28.88 - 45.00
Beta	0.56
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Assure Tech (Hangzhou)

Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China. It is also involved in POCT and plastic product manufacturing; online sales; pharmaceutical sales; and medical testing. In addition, the company offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veterinary tests, as well as Biochemistry, chronic disease monitoring systems, and reader and analyzers. Further, it offers infectious disease, fertility, fe... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2008

Employees 720

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688075

Full Company Profile

Financial Performance

In 2025, Assure Tech (Hangzhou)'s revenue was 451.26 million, a decrease of -16.54% compared to the previous year's 540.70 million. Earnings were 69.42 million, a decrease of -63.90%.

Financial Statements